Dongwha Pharm.Co.,Ltd (000020-KS) Stock Split, History Data
Working capital analysis
In terms of working capital, Dongwha Pharm.Co.,Ltd maintains a healthy position.
The total current assets of the company are valued at $237700038220.
This represents a growth rate of 4.471% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $72317114790, exhibiting a growth rate of 110.548% year-on-year.
The receivables, another significant portion of the current assets, are valued at $74484284853.
The year-on-year growth rate for receivables is 2.541%.
The inventory, which forms a critical part of the assets, is valued at $70697183860.
This represents a healthy year-on-year growth of 51.115%
On the liabilities side, the company's current liabilities total $106133854638.
This reflects a growth rate of 40.459% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
72317.11
34347.10
60479.64
58596.43
37779.18
40614.51
Receavebles
74484.28
72638.22
62266.68
62773.25
81837.58
80247.03
Inventory
70697.18
46783.64
36243.98
39504.17
33430.79
43717.60
Other
5284.39
411.09
178.34
135.23
169.67
240.89
Total Current Assets
237700.04
227527.47
220198.64
222743.49
235456.99
227887.46
Acc Payable
31412.27
22231.80
17118.71
18522.17
17322.51
29965.38
Short Term Debt
20371.55
4619.66
6418.48
11614.29
1793.24
0.00
Other Current Liab
52909.39
47508.78
5988.87
5940.23
6927.80
30832.91
Current Liabilities
106133.85
75562.34
66461.30
67494.00
55714.63
60798.28
Capital Structure
When examining the capital structure of Dongwha Pharm.Co.,Ltd, it is clear that the company manages a robust portfolio.
These earnings represent the profits that Dongwha Pharm.Co.,Ltd has chosen to reinvest in the business rather than distribute as dividends.
